AXTA vs EXP

AXTA's deterministic scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below the growth-based intrinsic value of $48.10 but above the conservative Graham Number of $22.25, suggesting mixed valuation signals. Despite solid profitability metrics like a 21.33% ROE and consistent earnings beats, revenue is contracting YoY by 2.40%, and insider activity is bearish with recent selling. Analysts recommend a 'buy' with a $36.71 target, implying moderate upside from current levels around $33.62.

Eagle Materials exhibits strong operational health with a Piotroski F-Score of 7/9 and exceptional ROE (28.77%), yet it faces a severe valuation disconnect. The current price of $208.76 trades at a significant premium to both the Graham Number ($118.75) and the Intrinsic Value ($92.68). While the balance sheet is liquid and profitability is superior to sector averages, negative YoY revenue and earnings growth, combined with a bearish technical trend, suggest limited near-term upside.